Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency

NCT05593588 · clinicaltrials.gov ↗

PHASE2

Phase

ENROLLING_BY_INVITATION

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Common Variable Immunodeficiency
Interstitial Lung Disease Due to Systemic Disease

Interventions

DRUG: Fisetin
DRUG: Placebo

Sponsor

Avni Joshi